Efficacy dilution in randomized placebo-controlled vaginal microbicide trials (2009)
Mâsse, Benoît R, Boily, Marie-Claude, Dimitrov, Dobromir, Desai, Kamal
Abstract Background To date different vaginal gel microbicides have been evaluated in phase 2b/3 trials, but none have demonstrated effectiveness for preventing HIV infection. Failure to demonstrate...
Geoff P. Garnett, Kamal Desai, John Williams
The influence of a vaccine with a range of different properties has been explored in a mathematical model of the spread of HIV in a heterosexual population, reflecting the generalized epidemics...
Geoff P. Garnett, Kamal Desai, John Williams
The influence of a vaccine with a range of different properties has been explored in a mathematical model of the spread of HIV in a heterosexual population, reflecting the generalized epidemics...
Desai, Kamal, Boily, Marie-Claude, Garnett, Geoff P, Mâsse, Benoît R, Moses, Stephen, Bailey, Robert C
Abstract Background A landmark randomised trial of male circumcision (MC) in Orange Farm, South Africa recently showed a large and significant reduction in risk of HIV infection, reporting MC...
The Development of Vaginal Microbicides for the Prevention of HIV Transmission (2005)
Jonathan Weber, Kamal Desai, Janet Darbyshire
Given that we still do not have an effective vaccine against HIV, the development of novel biomedical methods for preventing HIV transmission remains a top priority in controlling the HIV pandemic.
Thèse (Ph. D.)--Université Laval, 2001.
The Development of Vaginal Microbicides for the Prevention of HIV Transmission
Weber, Jonathan, Desai, Kamal, Darbyshire, Janet
Given that we still do not have an effective vaccine against HIV, the development of novel biomedical methods for preventing HIV transmission remains a top priority in controlling the HIV pandemic.
The Development of Vaginal Microbicides for the Prevention of HIV Transmission
Weber, Jonathan, Desai, Kamal, Darbyshire, Janet
Given that we still do not have an effective vaccine against HIV, the development of novel biomedical methods for preventing HIV transmission remains a top priority in controlling the HIV pandemic.